J4

• 生命科学 • 上一篇    下一篇

亮菌甲素在大鼠体内的绝对生物利用度

王岩1,2, 王中华2, 刘明远3, 董雷1, 顾景凯2   

  1. 1. 吉林大学 第一医院药剂科, 长春 130021; 2. 吉林大学 生命科学学院, 长春 130021;3. 佳木斯大学 基础医学院, 黑龙江 佳木斯 154007
  • 收稿日期:2007-06-10 修回日期:1900-01-01 出版日期:2008-01-26 发布日期:2008-01-26
  • 通讯作者: 顾景凯

Absolute Bioavailability of Armillarisin A in Rats

WANG Yan1,2, WANG Zhonghua2, LIU Mingyuan3, DONG Lei1, GU Jingkai2   

  1. 1. Department of Medication, First Hospital, Jilin University, Changchun 130021, China;2. College of Life Science, Jilin University, Changchun 130021, China;3. School of Basic Medical Sciences, Jiamusi University, Jiamusi 154007, Heilongjiang Province, China
  • Received:2007-06-10 Revised:1900-01-01 Online:2008-01-26 Published:2008-01-26
  • Contact: GU Jingkai

摘要: 采用液相色谱串联质谱(LC-MS/MS)法测定大鼠血浆中亮菌甲素的浓度, 研究亮菌甲素在大鼠体内药动学特征及其绝对生物利用度. 结果表明, 亮菌甲素灌胃给药(ig)1.44 mg和静脉注射给药(iv)0.9 mg后, 在大鼠体内的主要药动学参数达峰浓度(cmax)分别为(58.33±23.41),(825.25±92.13) μg/L, 半衰期(t1/2)分别为(1.55±0.43), (0.75±035) h, 血药浓度-时间曲线下面积(AUC0~t)分别为(41.87±7.54), (140.64±19.73) h·(μg/L). 经剂量校正后求得亮菌甲素在大鼠体内的绝对生物利用度(Fab)为18.61%.

关键词: 亮菌甲素, 药代动力学, 绝对生物利用度

Abstract: To investigate the pharmacokinetic characteristics of Armillarisin A and its absolute bioavailability in rats, 1.44 mg and 0.9 mg of Armillarisin A were given via ig and iv to SD rats, respectively; the plasma concentration of Armillarisin A in rats was determined by LCMS/MS. After ig administration of Armillarisin A, the main pharmacokinetic parameters cmax, t1/2, AUC0~t were (58.33±23.41) μg/L, (155±043) h, (4187±754) h·(μg/L), respectively; After iv administration of Armillarisin A, the major pharmacokinetic parameters cmax, t1/2, AUC0~t were (825.25±92.13) μg/L, (0.75±0.35) h, (140.64±19.73) h·(μg/L), respectively. The absolute bioavailability was 18.61% after correction of dosage.

Key words: Armillarisin A, pharmacokinetics, absolute bioavailability

中图分类号: 

  • R969.1